content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001834835</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001177648</issuerCik>
        <issuerName>Enanta Pharmaceuticals, Inc.</issuerName>
        <secFileNumber>001-35839</secFileNumber>
        <issuerAddress>
          <com:street1>500 Arsenal Street</com:street1>
          <com:city>Watertown</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02472</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>617-607-0800</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Tara Lynn Kieffer</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue</com:street1>
            <com:street2>6th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>7266</noOfUnitsSold>
        <aggregateMarketValue>92351</aggregateMarketValue>
        <noOfUnitsOutstanding>21179400</noOfUnitsOutstanding>
        <approxSaleDate>06/17/2024</approxSaleDate>
        <securitiesExchangeName>NYSE</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>02/13/2022</acquiredDate>
        <natureOfAcquisitionTransaction>PSU Release</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1064</amountOfSecuritiesAcquired>
        <paymentDate>02/13/2022</paymentDate>
        <natureOfPayment>Compensation</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>02/13/2023</acquiredDate>
        <natureOfAcquisitionTransaction>PSU Release</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>5000</amountOfSecuritiesAcquired>
        <paymentDate>02/13/2023</paymentDate>
        <natureOfPayment>Compensation</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>12/01/2022</acquiredDate>
        <natureOfAcquisitionTransaction>PSU Release</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1202</amountOfSecuritiesAcquired>
        <paymentDate>12/01/2022</paymentDate>
        <natureOfPayment>Compensation</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>06/17/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>03/14/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Tara Lynn Kieffer</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4034}]
text: 144
  0001834835
  XXXXXXXX
  LIVE
  0001177648
  Enanta Pharmaceuticals, Inc.
  001-35839
  500 Arsenal Street
  Watertown
  MA
  02472
  617-607-0800
  Tara Lynn Kieffer
  Officer
  Common Stock
  J.P. Morgan Securities LLC
  390 Madison Avenue
  6th Floor
  New York
  NY
  10017
  7266
  92351
  21179400
  06/17/2024
  NYSE
  Common Stock
  02/13/2022
  PSU Release
  Issuer
  N
  1064
  02/13/2022
  Compensation
  Common Stock
  02/13/2023
  PSU Release
  Issuer
  N
  5000
  02/13/2023
  Compensation
  Common Stock
  12/01/2022
  PSU Release
  Issuer
  N
  1202
  12/01/2022
  Compensation
  Y
  06/17/2024
  03/14/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Tara Lynn Kieffer